nicergoline has been researched along with Amentia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, YA; Jeong, H; Lee, S; Na, SH; Song, IU | 1 |
| Weinstein, JD | 1 |
| Dolezal, T; Fioravanti, M; Logina, I; Milanov, IG; Popescu, DC; Solomon, A; Winblad, B | 1 |
| Damulin, IV | 1 |
| Calzà, L; Giardino, L | 1 |
| Heidrich, H; Kugler, J | 1 |
| Venn, RD | 1 |
| Mateescu, R; Măties, R; Mihalas, G; Mihalas, IG; Popa, R; Schneider, F; Stefanigă, P | 1 |
| Crook, TH | 1 |
| Fioravanti, M; Flicker, L | 1 |
| Donoso, A; Santander, M; Sarce, H | 1 |
| Fukuda, M; Hata, A; Hayashida, S; Hiramatsu, K; Honda, H; Honda, M; Iwanami, A; Nakagome, K; Niwa, S; Sasaki, T | 1 |
| Ardia, A; Battaglia, A; Bruni, G; Sacchetti, G | 1 |
| Böhmer, F; Grünberger, J; Hochmayer, I; Neuhold, A; Paroubek, J; Saletu, B; Wicke, L | 1 |
4 review(s) available for nicergoline and Amentia
| Article | Year |
|---|---|
Therapeutic use of nicergoline.
Topics: Adrenergic alpha-Antagonists; Animals; Cerebrovascular Disorders; Dementia; Humans; Nicergoline; Nootropic Agents; Parkinson Disease; Postural Balance; Sensation Disorders | 2008 |
[Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice].
Topics: Adrenergic alpha-Antagonists; Brain Diseases; Dementia; Humans; Nicergoline; Nootropic Agents; Vasodilator Agents | 2010 |
Neuroprotection: a realistic goal for aged brain?
Topics: Acetylcholine; Aging; Animals; Basal Ganglia; Brain; Dementia; Dopamine; Humans; Neuroprotective Agents; Nicergoline; Nitric Oxide; Nootropic Agents; Prosencephalon; Rats; Receptors, N-Methyl-D-Aspartate; Recovery of Function; Vestibule, Labyrinth | 2004 |
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
Topics: Cognition Disorders; Dementia; Humans; Nicergoline; Nootropic Agents; Randomized Controlled Trials as Topic | 2001 |
5 trial(s) available for nicergoline and Amentia
| Article | Year |
|---|---|
[Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls].
Topics: Aged; Attention; Blood Pressure; Clinical Trials as Topic; Dementia; Ergolines; Female; Humans; Male; Mental Recall; Middle Aged; Nicergoline; Psychomotor Performance | 1984 |
Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry.
Topics: Aged; Aging; Dementia; Double-Blind Method; Drug Combinations; Female; Geriatric Assessment; Humans; Male; Meclofenoxate; Middle Aged; Niacin; Nicergoline; Orotic Acid; Psychotropic Drugs; Vasodilator Agents | 1994 |
[Effect of nicergoline on the intellectual performance (author's transl)].
Topics: Aged; Clinical Trials as Topic; Dementia; Double-Blind Method; Ergolines; Female; Humans; Intelligence Tests; Male; Nicergoline; Placebos | 1979 |
Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Dementia; Double-Blind Method; Ergolines; Female; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nicergoline; Random Allocation | 1989 |
[Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Ergolines; Evoked Potentials; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicergoline; Psychometrics | 1987 |
7 other study(ies) available for nicergoline and Amentia
| Article | Year |
|---|---|
Efficacy of nicergoline treatment in Parkinson's disease associated with dementia.
Topics: Aged; Cerebrovascular Circulation; Cognition; Dementia; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Nicergoline; Parkinson Disease; Vasodilator Agents | 2019 |
A unique and promising combination of medications for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Dementia; Disease Progression; Drug Design; Drug Therapy, Combination; Humans; Inflammation; Methylene Blue; Neurons; Nicergoline; Oxidative Stress; Pentoxifylline; Pyridoxamine; Pyrimidines | 2017 |
Review of clinical studies with ergots in gerontology.
Topics: Aged; Cerebrovascular Circulation; Dementia; Dihydroergotoxine; Double-Blind Method; Ergot Alkaloids; Humans; Nicergoline; Papaverine; Psychiatric Status Rating Scales | 1980 |
[Diagnosis and therapy of dementia syndrome. Italo-German symposium on primary and vascular dementia. 26-27 March 1993].
Topics: Dementia; Dementia, Vascular; Diagnosis, Differential; Humans; Nicergoline; Tomography, Emission-Computed; Vasodilator Agents | 1993 |
[Therapy of primary dementia based on modern concepts].
Topics: Adrenergic alpha-Antagonists; Alzheimer Disease; Dementia; Dementia, Multi-Infarct; Humans; Nicergoline | 1995 |
Nicergoline: parallel evolution of clinical trial methodology and drug development in dementias.
Topics: Adrenergic alpha-Antagonists; Alzheimer Disease; Clinical Trials as Topic; Dementia; Drug Evaluation; Humans; Mental Status Schedule; Nicergoline; Treatment Outcome | 1997 |
Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline.
Topics: Aged; Benzhydryl Compounds; Dementia; Electroencephalography; Evoked Potentials; Humans; Male; Morpholines; Nicergoline; Psychotropic Drugs; Reaction Time | 1992 |